Tox21_300193

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers, 7 USDMF, 5 CEP/COS, 1 JDMF, 2 EU WC, 5 NDC API, 4 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

154 Dossiers, 61 FDA Orange Book, 18 Europe, 3 Canada, 1 Australia, 53 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 50MG;300MG;120MG, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 27 Roquette, 26 Kerry, 18 Microlex e.U, 17 BASF, 12 Sigachi Industries, 12 SPI Pharma, 10 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 DFE Pharma, 7 Gangwal Chemicals, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Vasa Pharmachem, 4 Ingredion Pharma Solutions, 4 Actylis, 4 Prachin Chemical, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Lonza Capsugel, 3 Rochem International Inc, 3 Boai NKY Pharmaceuticals Ltd, 3 Pharmatrans-Sanaq, 3 DKSH, 2 Ulanqab Kema New Material, 2 Seppic, 2 Aeon Procare, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Qualicaps, 1 Pfanstiehl, 1 Zhejiang Huakang Pharmaceutical, 1 Kima Chemical, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 The Dow Chemical Company, 1 Jai Radhe Sales, 1 Shijiazhuang Huaxu Pharmaceutical

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 33 Direct Compression, 31 Disintegrants & Superdisintegrants, 23 Lubricants & Glidants, 22 Thickeners and Stabilizers, 22 Granulation, 19 Coating Systems & Additives, 15 Co-Processed Excipients, 15 Film Formers & Plasticizers, 14 Taste Masking, 13 Solubilizers, 13 Controlled & Modified Release, 10 Parenteral, 8 Empty Capsules, 8 Chewable & Orodispersible Aids, 5 Topical, 4 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 1 Soft Gelatin

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 21 Finished Drug Prices

MARKET PLACE

11 APIs, 5 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 Analytical Solutions, 1 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

8 News

8 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Tox21_300193. Original Data : Therapeutic Goods Administration Website

Tox21_300193

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers

7 USDMF

5 CEP/COS

1 JDMF

2 EU WC

5 NDC API

4 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

154 Dossiers

61 FDA Orange Book

18 Europe

3 Canada

1 Australia

53 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 50MG;300MG;120MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

27 Roquette

26 Kerry

18 Microlex e.U

17 BASF

12 Sigachi Industries

12 SPI Pharma

10 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 DFE Pharma

7 Gangwal Chemicals

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Vasa Pharmachem

4 Ingredion Pharma Solutions

4 Actylis

4 Prachin Chemical

4 Nanjing Well Pharmaceutical

4 ACG Worldwide

3 Lonza Capsugel

3 Rochem International Inc

3 Boai NKY Pharmaceuticals Ltd

3 Pharmatrans-Sanaq

3 DKSH

2 Ulanqab Kema New Material

2 Seppic

2 Aeon Procare

1 Shanghai Welltone Material Technology Co., Ltd

1 Qualicaps

1 Pfanstiehl

1 Zhejiang Huakang Pharmaceutical

1 Kima Chemical

1 Finar

1 Ideal Cures Pvt Ltd

1 The Dow Chemical Company

1 Jai Radhe Sales

1 Shijiazhuang Huaxu Pharmaceutical

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders

33 Direct Compression

31 Disintegrants & Superdisintegrants

23 Lubricants & Glidants

22 Thickeners and Stabilizers

22 Granulation

19 Coating Systems & Additives

15 Co-Processed Excipients

15 Film Formers & Plasticizers

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons